Skip to content
10-Q

Quarterly Report

REGENOCELL THERAPEUTICS, INC.

0001144204-11-065913

← back to feed
Filed
Nov 21, 2011 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2011 · Nov 15, 2011 81.96M sh
Capex Q3 2011 · Sep 30, 2011 $0
Capex Q3 2011 · Sep 30, 2010 $76.12K
Operating Cash Flow Q3 2011 · Sep 30, 2011 $150.88K
Operating Cash Flow Q3 2011 · Sep 30, 2010 −$58.36K
Cash And Equivalents Q3 2011 · Sep 30, 2011 $19.74K
Cash And Equivalents Q3 2011 · Dec 31, 2010 $3.44K
Cash And Equivalents Q3 2011 · Sep 30, 2010 $28.51K
Cash And Equivalents Q3 2011 · Dec 31, 2009 $102.08K
Stockholders Equity Q3 2011 · Sep 30, 2011 −$5.3M
Stockholders Equity Q3 2011 · Dec 31, 2010 −$4.36M
Stockholders Equity Q3 2011 · Dec 31, 2009 −$353.77K
Current Liabilities Q3 2011 · Sep 30, 2011 $2.3M
Current Liabilities Q3 2011 · Dec 31, 2010 $1.72M
Total Liabilities Q3 2011 · Sep 30, 2011 $5.56M
Total Liabilities Q3 2011 · Dec 31, 2010 $4.71M
Current Assets Q3 2011 · Sep 30, 2011 $162.22K
Current Assets Q3 2011 · Dec 31, 2010 $191.45K
Total Assets Q3 2011 · Sep 30, 2011 $260.39K
Total Assets Q3 2011 · Dec 31, 2010 $342.43K
Sga Expense Q3 2011 · Sep 30, 2011 $226.39K
Sga Expense Q3 2011 · Sep 30, 2011 $506.02K
Sga Expense Q3 2011 · Sep 30, 2010 $143.14K
Sga Expense Q3 2011 · Sep 30, 2010 $405.42K
Net Income Q3 2011 · Sep 30, 2011 −$544.87K
Net Income Q3 2011 · Sep 30, 2011 −$1.04M
Net Income Q3 2011 · Dec 31, 2010 −$4.06M
Net Income Q3 2011 · Sep 30, 2010 −$417.19K
Net Income Q3 2011 · Sep 30, 2010 −$915.91K
Operating Income Q3 2011 · Sep 30, 2011 −$315.64K
Operating Income Q3 2011 · Sep 30, 2011 −$640.78K
Operating Income Q3 2011 · Sep 30, 2010 −$410.34K
Operating Income Q3 2011 · Sep 30, 2010 −$658.07K
Revenue Q3 2011 · Sep 30, 2011 $162.37K
Revenue Q3 2011 · Sep 30, 2011 $618.81K
Revenue Q3 2011 · Sep 30, 2010 $172.03K
Revenue Q3 2011 · Sep 30, 2010 $738.86K